Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga April 27, 2015 at 08:08 AM EDT Celladon Corp (NASDAQ: CLDN) shares fell 74.49 percent to $3.49 in pre-market trading on the failed CUPID2 trial of MYDICAR in ... Read More >> Related Stocks: Akorn Inc Applied Materials Deutsche Bank Ag Marvell Technology Inc Tokyo Electron Ltd ADR